Q3 ’23 Earnings Call Safe Harbor Statement Thispresentationcontainsforward-lookingstatementsthatarebasedonthecurrentexpectationsandbeliefsofAmgen. Allstatements,otherthanstatementsofhistoricalfact,arestatementsthatcouldbedeemedforward-looking statements,includinganystatementsontheoutcome,benefitsandsynergiesofcollaborations,orpotentialcollaborations,withanyothercompany(includingBeiGene,Ltd.orKyowaKirinCo.,Ltd.),theperformanceofOtezla®(apremilast) (includinganticipatedOtezlasalesgrowthandthetimingofnon-GAAPE ...

Amgen Inc. (NASDAQ:AMGN) Q3 2023 Earnings Conference Call October 31, 2023 8:00 AM ET Company Participants Justin Claeys - VP, IR Robert Bradway - Chairman & CEO Murdo Gordon - EVP, Global Commercial Operations Vikram Karnani - Executive, Rare Disease Business David Reese - EVP, Research & Development Peter Griffith - CFO Conference Call Participants Michael Yee - Jefferies Yaron Werber - TD Cowen Terence Flynn - Morgan Stanley Salveen Richter - Goldman Sachs Jay Olson - Oppenheimer Umer Raffat - Evercore I ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ☑ EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ☐ EXCHANGE ACT OF 1934 Commission File Number: 001-37702 Amgen Inc. (Exact name of registrant as specified in its charter) Delaware 95-3540776 (State or other jurisdiction of (I.R.S. Employer incorporation or ...

Amgen Inc. (NASDAQ:AMGN) Amgen Conference Call Following European Society for Medical Oncology Congress 2023 October 24, 2023 8:00 AM ET Company Participants David Reese – Executive Vice President-Research and Development Taofeek Owonikoko – Division Chief-Division of Hematology-Oncology, UPMC Hillman Cancer Ctr. Tarlatamab Jean-Charles Soria – Senior Vice President-Research and Development Kevin Kelly – Chair, Department of Medical Oncology, Sidney Kimmel Medical College Conference Call Participants Salvee ...

Hematology/Oncology Update ESMO 2023 SAFE HARBOR STATEMENT This presentation contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa-Kirin Co., Ltd.), the performance of Otezla ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_f40de14a20e804d3a6af5c7e984f91c3.html ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_4f034bd9fec7da888ff907c6390a7800.html ...

https://reportify-1252068037.cos.ap-beijing.myqcloud.com/media/production/s_m_content_a86cfbdc1df4a04c795f2267227eb86a.html ...

Q2 ’23 Earnings Call Safe Harbor Statement Thispresentationcontainsforward-lookingstatementsthatarebasedonthecurrentexpectationsandbeliefsofAmgen. Allstatements,otherthanstatementsofhistoricalfact,arestatementsthatcouldbedeemedforward-looking statements,includinganystatementsontheoutcome,benefitsandsynergiesofcollaborations,orpotentialcollaborations,withanyothercompany(includingBeiGene,Ltd.orKyowa-KirinCo.,Ltd.),theperformanceofOtezla®(apremilast) (includinganticipatedOtezlasalesgrowthandthetimingofnon-GAAP ...

Amgen Inc. (NASDAQ:AMGN) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Arvind Sood – Vice President of Investor Relations Bob Bradway – Chairman and Chief Executive Officer Murdo Gordon – Executive Vice President, Global Commercial Operations Dave Reese – Executive Vice President, Research and Development Peter Griffith – Chief Financial Officer Conference Call Participants Mohit Bansal – Wells Fargo Michael Yee – Jefferies Salveen Richter – Goldman Sachs Jay Olson – Oppenh ...